BTIG Downgrades Talis Biomedical Corp. (TLIS) to Neutral, After CEO Transition Announcement
Tweet Send to a Friend
BTIG analyst Mark A. Massaro downgraded Talis Biomedical Corp. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
